Akebia Therapeutics, Inc.

Bank of New York Mellon Corp AKBA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

666,907

Value ($000)

1,074

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	1,074	0.0%	666,907	12/31/2025
2025 Q3	11/3/2025	1,854	0.0%	679,242	9/30/2025
2025 Q2	8/5/2025	2,241	0.0%	615,601	6/30/2025
2025 Q1	4/29/2025	948	0.0%	493,593	3/31/2025
2024 Q4	2/4/2025	945	0.0%	497,547	12/31/2024
2024 Q3	11/12/2024	620	0.0%	469,708	9/30/2024
2024 Q2	7/25/2024	617	0.0%	604,551	6/30/2024
2024 Q1	4/25/2024	34	0.0%	18,762	3/31/2024
2023 Q4	1/29/2024	89	0.0%	71,831	12/31/2023
2023 Q3	10/24/2023	82	0.0%	71,830	9/30/2023
2023 Q2	8/3/2023	66	0.0%	71,836	6/30/2023
2023 Q1	5/9/2023	40	0.0%	71,836	3/31/2023
2022 Q4	2/14/2023	41	0.0%	71,836	12/31/2022
2022 Q3	11/14/2022	23	0.0%	71,836	9/30/2022
2022 Q2	8/15/2022	26	0.0%	71,836	6/30/2022
2022 Q1	5/11/2022	459	0.0%	638,883	3/31/2022
2021 Q4	2/11/2022	1,413	0.0%	624,845	12/31/2021
2021 Q3	11/18/2021	1,704	0.0%	591,829	9/30/2021
2021 Q2	8/11/2021	2,130	0.0%	562,155	6/30/2021
2021 Q1	5/13/2021	2,019	0.0%	596,229	3/31/2021
2020 Q4	2/9/2021	1,843	0.0%	657,911	12/31/2020
2020 Q3	11/12/2020	1,450	0.0%	578,026	9/30/2020
2020 Q2	8/12/2020	8,573	0.0%	631,308	6/30/2020
2020 Q1	5/6/2020	4,480	0.0%	591,102	3/31/2020
2019 Q4	2/14/2020	4,376	0.0%	692,358	12/31/2019